Suscribirse

A prognostic rule for elderly patients admitted with community-acquired pneumonia - 08/09/11

Doi : 10.1016/S0002-9343(98)00369-6 
Harry A Conte, MD a, b, , Ya-Ting Chen, PhD a, b, Wajahat Mehal, MD a, b, D Phil a, b, Jeanne D Scinto, PhD, MPH a, b, Vincent J Quagliarello, MD a, b
a Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut USA 
b Connecticut Peer Review Organization, Middletown (JDS), Connecticut, USA 

*Requests for reprints should be addressed to Harry A. Conte, MD, Section of Infectious Diseases, Yale University School of Medicine, LCI 800, 333 Cedar Street, New Haven, Connecticut 06520

Abstract

PURPOSE: We sought to identify admission characteristics predicting mortality in elderly patients hospitalized with community-acquired pneumonia and to develop a prognostic staging system and discriminant rule.

PATIENTS AND METHODS: We retrospectively analyzed data from 2,356 patients aged ≥65 years admitted with community-acquired pneumonia. Multivariable analyses of a derivation cohort (n = 1,000) identified characteristics associated with hospital mortality. A staging system and discriminant rule based on these characteristics were tested in a validation cohort (n = 1,356). Our discriminant rule was compared with a rule formulated from a heterogeneous adult population with community-acquired pneumonia.

RESULTS: Hospital mortality rates were 9% (derivation cohort) and 12% (validation cohort). We identified five independent predictors of mortality: age ≥85 years [odds ratio 1.8 (95% confidence interval 1.1–3.1)], comorbid disease [odds ratio 4.1 (2.1–8.1)], impaired motor response [odds ratio 2.3 (1.4–3.7)], vital sign abnormality [odds ratio 3.4 (2.1–5.4)], and creatinine level ≥1.5 mg/dL [odds ratio 2.5 (1.5–4.2)]. These variables stratified patients into four distinct stages with increasing mortality in the derivation cohort (Stage 1, 2%; Stage 2, 7%; Stage 3, 22%; Stage 4, 45%; P = 0.001) as well as in the validation cohort (Stage 1, 4%; Stage 2, 11%; Stage 3, 23%; Stage 4, 41%; P = 0.001). The discriminant rule developed from the derivation cohort had greater overall accuracy (77.1%) in the validation cohort than a rule formulated from a heterogeneous adult population (68.0%, P = 0.001).

CONCLUSION: Elderly patients with community-acquired pneumonia have characteristics at admission that can predict mortality. Our staging system and discriminant rule improve prognostic stratification of these patients.

El texto completo de este artículo está disponible en PDF.

Esquema


 The analyses on which this publication is based were performed under Contract Number 500-96-P549, entitled “Utilization and Quality Control Peer Review Organization for the State of Connecticut” sponsored by the Health Care Financing Administration, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.


© 1999  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 1

P. 20-28 - janvier 1999 Regresar al número
Artículo precedente Artículo precedente
  • Association of silicone breast implants with immunologic abnormalities: a prospective study
  • Elizabeth W Karlson, Susan E Hankinson, Matthew H Liang, Jorge Sanchez-Guerrero, Graham A Colditz, Barbara J Rosenau, Frank E Speizer, Peter H Schur
| Artículo siguiente Artículo siguiente
  • Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction
  • Mitchell S. Cappell, Frank M. Iacovone

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.